Navigation Links
Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
Date:9/25/2008

Results to be Presented at the North American Menopause Society 19th Annual

Meeting

EMERYVILLE, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) will present an abstract in a presentation on their new drug candidate, VG101, for the treatment of vaginal dryness, at the 19th Annual Meeting of the North American Menopause Society in Orlando, Florida on September 26, 2008. Dr. Mary Tagliaferri, president and chief medical officer of Bionovo, will provide seminal information on the company's second estrogen receptor beta selective drug candidate that will be entering clinical trials shortly. Bionovo's drug candidate, VG101, is designed to treat postmenopausal vaginal dryness, a condition that affects over 40 million women.

The presentation will describe the mechanism of action of the company's selective estrogen receptor (ER) beta drug candidate and explain the safety advantages of this more highly selective estrogen receptor modulator, VG101, when compared to the currently available hormonal therapies for this indication. The presentation will detail the complete analysis of VG101 in both in vivo and in vitro models as well as present the clinical trial design for their upcoming Phase 1/2 study to evaluate the preliminary safety and efficacy of VG101 in a cohort of postmenopausal women. The presentation will include direct comparisons to existing estrogen therapies, showing VG101's superior efficacy at a cellular level.

"Vaginal dryness is a very painful, day to day, quality of life concern for over 50% of menopausal women. The only available FDA-approved treatment for women is estrogen, which has been proven to increase the risks for a number of potentially fatal dis
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the Bank of America Merrill Lynch 2015 ... a.m. Pacific time from the Encore at the Wynn in ... the presentation can be accessed at www.meipharma.com . A ...
(Date:5/6/2015)... , May 6, 2015  TriStar Wellness Solutions(R), ... that targets opportunities in the advanced wound care ... Oregon based wholly owned independent subsidiary ... funding from the National Institutes of Health (NIH) ... that is able to be delivered by a ...
(Date:5/6/2015)... , May 6, 2015  Genomic Health, Inc. (Nasdaq: ... , Chairman of the Board, Chief Executive Officer & ... Lynch 2015 Healthcare Conference in Las Vegas ... Pacific Time (PT). To access the live ... the  Investor Relations  section of the company,s web site ...
Breaking Medicine Technology:MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 3Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 4Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 5Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 2Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 3
... , , ROSH ... of innovative solutions for the advanced chronic,wound management market, ... Food and Drug Administration (FDA) to market its new,SilverStream(TM) ... Over-the-Counter version of the SilverStream product. , ...
... , , , , ... NXTM ), a leading manufacturer of innovative dialysis products, ... and their partners will be embarking on a week-long, conventional ... The cruise, dubbed the "2010 Freedom Cruise: We,re Taking Home ...
Cached Medicine Technology:EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4
(Date:5/6/2015)... Topical BioMedics, Inc., announces its May Pain Management Webinar will ... streamed live and then archived and accessible on demand 24/7. ... clicking on the following link: http://bit.ly/PMW_FIBRO . ... the webinar, and questions may also be submitted in advance ... the May webinar is “What You need to Know about ...
(Date:5/6/2015)... Cloud security companies Sookasa Inc ... partnership to help small-to-medium businesses secure their sensitive data ... are teaming up to transition SafeMonk customers to Sookasa’s ... to welcome SafeMonk users to the Sookasa family, and ... SafeMonk, the global powerhouse SafeNet (now Gemalto IDSS), are ...
(Date:5/6/2015)... Arizona (PRWEB) May 06, 2015 ... IMMEDIATE RELEASE , Med Ag Ventures, Inc. (MAV), ... manufacturing capacity of its Arizona based Phoenician Engineering ... grinders last September. MAV recently achieved profitability from ... network expanded from 100 at the end of ...
(Date:5/6/2015)... Hope For The Warriors® and American ... at the New York Athletic Club on April 21, ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... local and nationwide military families. The Barry Fixler Foundation/Semper ...
(Date:5/6/2015)... 06, 2015 The Jefferson Awards ... to activating and celebrating public service, announced today ... Health, as an Outstanding Employee Volunteer Organization. Champions ... Awards Foundation, are dedicated to building a culture ... decade, Highmark Health has recognized employees who volunteer ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:4th Annual Casino Night Draws Support for Military Families in New York City Region 2Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4
... rapidly changing the clinical practice of oncology. As scientists ... development of new tools capable of multiple, inexpensive biomarker ... essential to the success of genetically informed and personalized ... now developed a microfluidic image cytometry (MIC) platform that ...
... a single rock being overturned or an entire mountaintop ... processes, and vice versa. Ecological scientists will discuss findings ... growth to the diversity of insect species on green ... buildingsat the Ecological Society of America,s 95th Annual Meeting ...
... , , , , , ... , , AUDIO: ... School of Medicine... , Click here for more information. ... , , , , , ...
... HealthDay Reporter , MONDAY, August 2 (HealthDay News) -- ... than normal are at greater risk of developing artery-clogging ... of the arteries leading to heart disease, a new ... common assumption that modestly high cholesterol levels are nothing ...
... August 2, 2010 From the many images sent home ... viewed the plight of their country,s combat-weary veterans as stark ... But recent research at Washington State University (WSU) suggests that, ... often sets the trajectory of the balance of their lives. ...
... PICK: Boosting the efficacy of anticancer vaccines ... anticancer vaccines, which are designed to boost the patient,s ... example, the viruses used to deliver the tumor protein ... the patient,s immune system, inducing neutralizing and suppressive responses. ...
Cached Medicine News:Health News:New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors 2Health News:New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors 3Health News:Scientists unravel human-ecosystem interactions 2Health News:Scientists unravel human-ecosystem interactions 3Health News:Scientists unravel human-ecosystem interactions 4Health News:Colitis patients diagnosed later in life tend to have better disease outcomes 2Health News:Colitis patients diagnosed later in life tend to have better disease outcomes 3Health News:Colitis patients diagnosed later in life tend to have better disease outcomes 4Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 2Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 3Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 4Health News:Sociologist finds combat veterans face more lifelong socioeconomic challenges 2Health News:JCI online early table of contents: August 2, 2010 2Health News:JCI online early table of contents: August 2, 2010 3Health News:JCI online early table of contents: August 2, 2010 4Health News:JCI online early table of contents: August 2, 2010 5Health News:JCI online early table of contents: August 2, 2010 6
... refrigerator is specially designed ... blood in standard 500ml ... Standard AS3864 1997. Quiet ... utilising CFC Free refrigerant ...
TBR-720-2-GD is large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standard AS38...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... circulating testosterone exists as unbound or free ... to SHBG with high affinity [1], while ... Both the albumin-bound and free fractions may ... testosterone action. Measurement of the free or ...
Medicine Products: